These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 565235)

  • 21. Modification of apomorphine induced stereotypies in rates by aversive conditioning.
    Gale KN; Murray JP; Horita A
    Proc West Pharmacol Soc; 1975; 18():375-9. PubMed ID: 1237143
    [No Abstract]   [Full Text] [Related]  

  • 22. Ergoline derivative LEK-8829-induced turning behavior in rats with unilateral striatal ibotenic acid lesions: interaction with bromocriptine.
    Sprah L; Zivin M; Sket D
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1093-100. PubMed ID: 10027846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stereotypy following acute administration of l-alpha-acetylmethadol (LAAM) in the rat.
    Henderson GL; Westkaemper R
    Proc West Pharmacol Soc; 1975; 18():204-7. PubMed ID: 1237140
    [No Abstract]   [Full Text] [Related]  

  • 24. Dopamine-agonist drugs and cerebral electrical activity in the rabbit.
    Savoldi F; Tartara A; Bo P
    Farmaco Sci; 1979 Jun; 34(6):526-34. PubMed ID: 572783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bromocriptine: a rather specific stimulant of dopamine receptors regulating dopamine metabolism.
    Di Chiara G; Vargiu L; Porceddu ML; Gessa GL
    Adv Biochem Psychopharmacol; 1977; 16():443-6. PubMed ID: 578073
    [No Abstract]   [Full Text] [Related]  

  • 26. Central monoamine synapses as sites of action for ergot drugs.
    Fuxe K; Ogren SO; Agnati LF; Andersson K; Hall H; Köhler C; Fredholm B
    Adv Biochem Psychopharmacol; 1980; 23():41-62. PubMed ID: 6104914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypothermic action of bromocriptine.
    Calne DB; Claveria LE; Reid JL
    Br J Pharmacol; 1975 May; 54(1):123-4. PubMed ID: 1139073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Behavioral effects of dopamine agonists increase with age.
    Smith RC; Leelavathi DE; Lauritzen AM
    Commun Psychopharmacol; 1978; 2(1):39-43. PubMed ID: 566185
    [No Abstract]   [Full Text] [Related]  

  • 29. Proceedings: Mechanisms involved in the effect of apomorphine on the extrapyramidal system of the rat.
    Loew DM; Vigouret JM
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287 Suppl():R10. PubMed ID: 1170505
    [No Abstract]   [Full Text] [Related]  

  • 30. Behavioral effects of dopamine agonists across the estrous cycle in rats.
    Steiner M; Katz RJ; Carroll BJ
    Psychopharmacology (Berl); 1980; 71(2):147-51. PubMed ID: 6777814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antagonism of apomorphine-induced stereotyped behaviour by piribedil (ET 495) in young chicks [proceedings].
    Osuide G; Sokomba EN
    West Afr J Pharmacol Drug Res; 1977 Jun; 4(1):56P-57P. PubMed ID: 564100
    [No Abstract]   [Full Text] [Related]  

  • 32. A comparison between amantadine and bromocriptine using the stereotyped behaviour response test (SBR) in the rat.
    Schnieden H; Cox B
    Eur J Pharmacol; 1976 Sep; 39(1):133-41. PubMed ID: 134898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effects of bifemelane on central dopaminergic and cholinergic systems in rats].
    Ushijima I; Tsutsumi C; Hara T; Soeda K; Kishimoto O; Kaneyuki H; Mizuki Y; Yamada M
    Yakubutsu Seishin Kodo; 1988 Dec; 8(4):463-70. PubMed ID: 2907957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apomorphine-induced turning behavior in 6-hydroxydopamine lesioned rats is increased by histidine and decreased by histidine decarboxylase, histamine H1 and H2 receptor antagonists, and an H3 receptor agonist.
    Liu CQ; Hu DN; Liu FX; Chen Z; Luo JH
    Pharmacol Biochem Behav; 2008 Sep; 90(3):325-30. PubMed ID: 18452981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective affinities of bromocriptine and lergotrile for rat limbic dopamine binding sites [proceedings].
    Blackburn KJ; Bremner RM; Greengrass PM; Morville M; Davey MJ
    Br J Pharmacol; 1978 Nov; 64(3):413P. PubMed ID: 31219
    [No Abstract]   [Full Text] [Related]  

  • 36. Neurochemical and neuropharmacological investigations with four ergot derivatives: bromocriptine, dihydroergotoxine, CF 25-397 and CM 29-712.
    Vigouret JM; Bürki HR; Jaton AL; Züger PE; Loew DM
    Pharmacology; 1978; 16 Suppl 1():156-73. PubMed ID: 565520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bromocriptin and methylergometrine: pharmacological approach of the mechanism of their central effects.
    Puech AJ; Simon P; Chermat R; Boissier JR
    Pharmacol Res Commun; 1977 Mar; 9(3):299-306. PubMed ID: 577309
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of catechol-O-methyltransferase inhibitors on brain apomorphine concentrations and stereotyped behaviour in the rat.
    Symes AL; Lal S; Sourkes TL
    J Pharm Pharmacol; 1975 Dec; 27(12):947-9. PubMed ID: 2669
    [No Abstract]   [Full Text] [Related]  

  • 39. The pharmacological evaluation of pergolide mesylate as a potential anti-parkinson agent.
    Koller WC; Weiner WJ; Diamond BI; Nausieda PA; Klawans HL
    Neuropharmacology; 1980 Sep; 19(9):831-7. PubMed ID: 7191490
    [No Abstract]   [Full Text] [Related]  

  • 40. A simple device to measure stereotyped rearing of the rat in an objective and quantitative way.
    Decsi L; Gács E; Zámbó K; Nagy J
    Neuropharmacology; 1979; 18(8-9):723-5. PubMed ID: 573874
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.